Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Ramon Varcoe
Research Area(s) / Expertise:

Peripheral Artery Disease - General

 Job title: Associate Professor of Vascular Surgery
Professor Varcoe is a vascular surgeon at Sydney’s Prince of Wales Hospitals where he is director of the operating theatres and of the Vascular Institute, one of Australia’s most prestigious clinical trials centres. His clinical practice specialises in the minimally invasive treatment of aortic conditions, carotid disease and the full gamut of occlusive arterial disease of the lower limb for… View more
ECR Hernadez
Author(s): Dae-Hyun Lee , José M de la Torre Hernández Added: 3 years ago
When Andreas Grüntzig introduced balloon coronary angioplasty in 1977 it represented the first alternative to coronary artery bypass graft surgery. However, balloon dilatation had inherent limitations – including elastic recoil and vessel closure in the acute phase, as well as negative remodelling and restenosis in the late phase – which limited its applicability and further expansion. In the… View more

Intervention
Author(s): Savio D’Souza , Giuseppe Ferrante , Pawel Tyczynski , et al Added: 3 years ago
Percutaneous coronary intervention (PCI) deploying metallic stents is now a standard and routine procedure for the treatment of flow-limiting coronary stenosis in patients with ischaemic heart disease and is an alternative to surgery. Stents were invented to overcome limitations of balloon angioplasty coronary dissections, acute and subacute elastic recoil, intimal hyperplasia and negative vessel… View more

Intervention
Deferred Stenting for Heavy Thrombus Burden During PCI for STEMI
Author(s): Akshyaya Pradhan , Monika Bhandari , Pravesh Vishwakarma , et al Added: 3 years ago

MI/ACS
CRT 24: The ABSORB Trial
Author(s): David Power Added: 1 month ago
CRT 24 - We are joined in this short virtual interview by investigator, Dr David Power (Mount Sinai Hospital, US) to discuss the latest findings from the ABSORB trial series, revealed in 2024 at the CRT conference.ABSORB III is a prospective, randomized, single-blind, multicenter trail aiming to support the pre-market approval of the Absorb bioresorbable vascular scaffold (Abbott) for the… View more

Vascular Disease and Surgery

Intervention
EuroPCR 22: CRUZ-HBR Indicates Use Of Supraflex™ Cruz Stent Is Favourable
Author(s): David Leistner Added: 1 year ago
In this short interview from EuroPCR 22, Prof David Leistner (Charité Universitätsmedizin, DE) joins us on-site to outline the key findings of the CRUZ-HBR registry. This was a real-world study to confirm the outcomes of the Supraflex™ Cruz stent (SMT Ltd) in all-comer patients, where half of the cohort were at high bleeding risk. Results suggest that the Supraflex™ Cruz stent had a favourable… View more

Intervention
EuroPCR 2021: 2-year Results from the MAGSTEMI Trial
Author(s): Luis Ortega-Paz Added: 2 years ago
Dr Luis Ortega-Paz (Hospital Clinic de Barcelona, Barcelona, ES) discusses the 2-year results from the MAGSTEMI Trial. Thestudy comparedthe in-stent/scaffold vasomotionbetweenMgBRS and permanent metallic sirolimus-eluting stent (SES) at 12-month follow-up in ST-segment–elevation myocardial infarction patients. Questions: 1. What was the rationale for the MAGSTEMI Trial? 2. Please remind us… View more

MI/ACS

Intervention
EuroPCR 2021: Findings From the POEM Study
Author(s): Giulio G Stefanini Added: 2 years ago
Dr Giulio Stefanini (Humanitas Research Hospital, Milan, IT) discusses the findings from the multicentre POEM trial.The trial assessed the safety of the bioresorbable polymer-coated everolimus-eluting Synergy® stent in CAD patients undergoing PCI, followed by 1-month dual antiplatelet therapy (DAPT) in patients at high bleeding risk (HBR). Questions: 1. What is the POEM Study and what does it… View more

Anticoagulation

Intervention
View from the Thoraxcenter: EuroPCR 23 Late-breaking Science Preview
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 11 months ago
Join Prof Nicolas Van Mieghem and Dr Joost Daemen, interventional experts from the Thoraxcenter at Erasmus MC in Rotterdam, as they provide a comprehensive preview of the late-breaking trials and studies that will be presented at EuroPCR 2023. In this dynamic episode, they offer valuable insights into the latest developments in interventional clinical and research science. Studies include:… View more

Intervention
Craig Thompson
Job title: Director
Personal History Dr. Thompson is based in Hartford Connecticut, where he works as Director of Cardiac Catheterization and Interventional Cardiology for Hartford HealthCare. Academic History Dr. Thompson holds an undergraduate degree from the University of Southern Mississippi, a medical degree from the University of Mississippi and a Masters of Medical Science in clinical investigation… View more